Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
48.00    0.00 (0.00%)
Bid:
47.00
Ask:
49.00
Spread: 2.00 (4.255%)
Market Cap: £7.31m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Trading Update

17 Jul 2025 07:00

RNS Number : 3858R
Transense Technologies PLC
17 July 2025
 

 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

 

 

17 July 2025

 

 

Transense Technologies plc

 

("Transense" or "the Company")

 

Year-end trading update

 

Transense Technologies plc, the provider of specialist sensor technology and measurement solutions, is pleased to issue a trading update for its financial year ended 30 June 2025 ("FY25") based on unaudited management information. The Company is continuing its growth trajectory and delivering on its strategic plan.

 

Financial highlights

 

Total revenue for the year increased by 33% to £5.6m (FY24: £4.2m), as follows:

 

  SAWsense revenue[1&3] up 120% to £1.1m (FY24: £0.5m)

  Translogik revenue up 18% to £1.3m (FY24: £1.1m)

  Bridgestone iTrack royalty income[3] up 19% to £3.1m (FY24: £2.6m)

 

SAWsense and Translogik combined revenue in the second half of the financial year was up 67% on the first half (FY25H2: £1.5m, FY25H1: £0.9m), demonstrating increasing traction and accelerating revenue growth within these product lines.

 

Adjusted PBT[2] for the year is expected to be approximately £1.6m; an increase of 8% on prior year (FY24: £1.4m), in line with market expectations.

 

Net cash at 30 June 2025 was £1.1m (30 June 2024: £1.3m), with a fourth quarter royalty receivable of approximately £0.8m[3] (30 June 2024: £0.7m) at the end of July.

 

Commercial and operational highlights

 

SAWsense

  Deepening customer relationships in aerospace, motorsport and eDrives sectors contributed to increased revenue

  Development projects underway with two leading global companies and a niche manufacturer in robotics

  Healthy pipeline of opportunities from both existing and new customers in focus markets

  Investment in next generation components and in-house production capabilities progressing on time and within budget

  Further strengthening of operational, technical, and business development teams to position the business for sustained expansion

 

Translogik

  New customer relationships and routes to market delivered overall sales growth, despite some headwinds in established premium commercial vehicle tyre market

  Established new distribution channels in the USA, Southeast Asia and South America

  Completed first software reseller agreement and closed initial contracts under subscription business model

  Reorganised business development activities to better align with future growth plan

  Development projects well underway for next generation product range and opening of new market sectors

 

Bridgestone iTrack royalty income

  Volume increase in installed base significantly ahead of expectation

  Royalty growth constrained by weakening US dollar in H2, partially mitigated by credit to opex from gains on FX hedging instruments

  Planned 40% reduction in unit royalty rate applies from July 2025 as per original agreement

 

Outlook and audited results

 

The directors are confident that both of the Company's operating businesses are well placed to deliver further growth in the upcoming financial year, and remain positive regarding future prospects.

 

Final audited results for the year ended 30 June 2025, together with a more detailed update on trading and outlook, are expected to be announced towards the end of September 2025.

 

Nigel Rogers, Executive Chairman commented:

 

"The increased traction within in our core product lines is demonstrated by our accelerating revenue growth and shows that our strategy is delivering. Going into the new financial year, we have strong pipeline giving management confidence in meeting market expectations for FY26 and remain excited about the opportunity to significantly scale the business over the coming years."

 

[1] SAWsense revenue includes grant income of £0.38m (FY24: £0.05m). 

[2] Net Profit Before Taxation before deduction of Share Based Payments charge

[3] Bridgestone iTrack royalty income and year end receivable are based on rates of foreign exchange prevailing at the year end. Actual rates may differ at the date of receipt.

 

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Ryan Maughan (Managing Director)

Melvyn Segal (Chief Financial Officer)

Via Investor Relations

(see below)

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Adrian Hadden / Callum Davidson (Corporate Finance)

Jasper Berry (Sales)

0207 220 0500

Investor Relations

Anice McNamee

Tel: +44 (0)1869 238380

Investor.relations@transense.co.uk

 

 

Notes to Editors:

 

Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies advanced sensor technology and measurement solutions used by some of the world's leading companies to improve performance, efficiency, and safety in demanding, mission critical applications. Transense currently operates through two active business segments:

 

SAWsense - designs, supplies and licences advanced sensor solutions based on proven, patent protected Surface Acoustic Wave (SAW) technology to world leading companies in aerospace, automotive, and industrial machinery (including robotics), enabling improved efficiency and performance of their products. Key customers include GE Aerospace, Parker Meggitt, McLaren Applied, Airbus and several other confidential Tier One automotive, aerospace and industrial machinery suppliers.

 

Translogik - develops smart, connected commercial vehicle tyre inspection equipment to many of the world's leading tyre suppliers, fleet operators and service centres. Enabling accurate measurement and digital capture of safety-critical tyre condition data, used to reduce operating costs, improve safety and provide audit records for regulatory compliance. Key customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), and leading independent providers of vehicle fleet maintenance management software, and a growing list of international territory distribution partners.

 

In addition, Transense earns residual royalty income from Bridgestone iTrack - a tyre monitoring system for off-highway vehicles that was developed by Translogik. The associated sales, support and development infrastructure were sold to Bridgestone Corporation, the world's largest tyre producer, in June 2020, and the intellectual property was licensed exclusively to Bridgestone under a ten-year deal expiring in 2030.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKABKFBKDDOD
Date   Source Headline
21st Jun 202211:21 amRNSDirector/PDMR shareholding – acquisition of shares
31st May 20225:00 pmRNSTotal Voting Rights
27th May 20227:00 amRNSTransaction in own shares & TVR
26th May 20223:57 pmRNSHolding(s) in Company
24th May 20227:15 amRNSTransaction in own shares & TVR
19th May 20227:00 amRNSTransaction in Own Shares & TVR
17th May 20227:00 amRNSTRT wins place on TDAP & £135k Grant
16th May 20227:00 amRNSTransaction in Own Shares & TVR
11th May 20227:00 amRNSSAW Update
9th May 20227:00 amRNSTransaction in own shares & TVR
3rd May 20227:00 amRNSTransaction in own shares & TVR
26th Apr 20228:54 amRNSTransaction in Own Shares
19th Apr 20227:00 amRNSTransaction in Own Shares
2nd Mar 20225:15 pmRNSHolding(s) in Company
28th Feb 20227:00 amRNSDirector/PDMR - acquisition of shares
22nd Feb 20227:02 amRNSGrant of share options to employees
22nd Feb 20227:01 amRNSShare Repurchase Programme
22nd Feb 20227:00 amRNSInterim Results & Investor Presentation
31st Jan 20227:00 amRNSNotice of Results & Investor Presentation
23rd Dec 20212:51 pmRNSHolding(s) in Company
22nd Dec 20214:11 pmRNSDirector/PDMR Shareholding
7th Dec 20214:25 pmRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSDirector/PDMR Shareholding - Acquisition of Shares
24th Nov 20217:00 amRNSDirector/PDMR shareholding – acquisition of shares
23rd Nov 202112:47 pmRNSResult of AGM
23rd Nov 20217:00 amRNSAGM Trading Update and Director Appointments
11th Nov 202111:40 amRNSHolding(s) in Company
2nd Nov 20217:01 amRNSAppointment of Additional SAWCAP Member
2nd Nov 20217:00 amRNSAGM Attendance & Investor Presentation
27th Oct 20217:00 amRNSAnnual Report, Notice of AGM & Investor Pres
4th Oct 20217:00 amRNSGrant of Options/PDMR Dealing
28th Sep 20217:00 amRNSFinal Results & Investor Presentation
14th Sep 20217:00 amRNS5 year JCA with McLaren Applied Ltd for SAW Tech
3rd Sep 20214:38 pmRNSHolding(s) in Company
31st Aug 20215:00 pmRNSTotal Voting Rights
26th Aug 20217:00 amRNSNotice of Annual Results & Investor Presentation
18th Aug 20213:30 pmRNSExercise of warrants
23rd Jul 20217:00 amRNSDirector/PDMR Shareholding
21st Jul 20217:00 amRNSNew member of Commercial Advisory Panel
5th Jul 20217:00 amRNSYear End Trading Update
2nd Jul 20211:12 pmRNSHolding(s) in Company
23rd Jun 20217:00 amRNSDirector/PDMR Shareholding
9th Apr 202110:05 amRNSHolding(s) in Company
15th Mar 20217:00 amRNSHolding(s) in Company
19th Feb 20214:12 pmRNSHolding(s) in Company
18th Feb 20211:21 pmRNSDirector/PDMR shareholding
17th Feb 202110:34 amRNSDirector/PDMR shareholding
17th Feb 20217:00 amRNSInterim Results & Investor Presentation
12th Feb 202112:48 pmRNSFurther re. Completion of Capital Reduction
1st Feb 20217:00 amRNSNotice of Results & Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.